Differing deregulation of HER2 in primary gastric cancer and synchronous related metastatic lymph nodes

BACKGROUND: The aim of this study was to investigate how differences in expression of HER2 between primary gastric cancers (PGCs) and their corresponding metastatic lymph nodes (LMNs) might affect its potential as a prognostic indicator in treatments including anti-HER2 agents. METHODS: The analysis...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kochi, Mitsugu, Fujii, Masashi, Masuda, Shinobu, Kanamori, Noriaki, Mihara, Yoshiaki, Funada, Tomoya, Tamegai, Hidenori, Watanabe, Megumu, Suda, Hiroshi, Takayama, Tadatoshi
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2013
Témata:
Methodology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3937244/
https://ncbi.nlm.nih.gov/pubmed/24261710
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1746-1596-8-191
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky